Benzinga | Nov 4, 2020 08:30AM EST

BTIG Maintains Buy on Veracyte, Raises Price Target to $42

BTIG analyst Sung Ji Nam maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $38 to $42.